FI940306A0 - Menetelmä kiraalisten tiatsolidiini-2,4-dionijohdannaisten synteesissä tarvittavien välituotteiden valmistamiseksi - Google Patents

Menetelmä kiraalisten tiatsolidiini-2,4-dionijohdannaisten synteesissä tarvittavien välituotteiden valmistamiseksi

Info

Publication number
FI940306A0
FI940306A0 FI940306A FI940306A FI940306A0 FI 940306 A0 FI940306 A0 FI 940306A0 FI 940306 A FI940306 A FI 940306A FI 940306 A FI940306 A FI 940306A FI 940306 A0 FI940306 A0 FI 940306A0
Authority
FI
Finland
Prior art keywords
preparation
intermediates
synthesis
dione derivatives
thiazolidine
Prior art date
Application number
FI940306A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI940306A (fi
Inventor
George J Quallich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI940306A publication Critical patent/FI940306A/fi
Publication of FI940306A0 publication Critical patent/FI940306A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI940306A 1991-07-22 1994-01-21 Menetelmä kiraalisten tiatsolidiini-2,4-dionijohdannaisten synteesissä tarvittavien välituotteiden valmistamiseksi FI940306A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73356491A 1991-07-22 1991-07-22
PCT/US1992/005433 WO1993002060A1 (en) 1991-07-22 1992-07-01 Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives

Publications (2)

Publication Number Publication Date
FI940306A FI940306A (fi) 1994-01-21
FI940306A0 true FI940306A0 (fi) 1994-01-21

Family

ID=24948157

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940306A FI940306A0 (fi) 1991-07-22 1994-01-21 Menetelmä kiraalisten tiatsolidiini-2,4-dionijohdannaisten synteesissä tarvittavien välituotteiden valmistamiseksi

Country Status (21)

Country Link
US (1) US5512689A (pt)
EP (1) EP0595868B1 (pt)
JP (1) JP2671962B2 (pt)
AT (1) ATE173728T1 (pt)
AU (1) AU660701B2 (pt)
CA (1) CA2111445C (pt)
DE (1) DE69227689T2 (pt)
DK (1) DK0595868T3 (pt)
ES (1) ES2123562T3 (pt)
FI (1) FI940306A0 (pt)
HU (1) HUT70412A (pt)
IE (1) IE922359A1 (pt)
IL (1) IL102574A (pt)
MX (1) MX9204278A (pt)
MY (1) MY131277A (pt)
NO (1) NO940227L (pt)
NZ (1) NZ243651A (pt)
PT (1) PT100710B (pt)
TW (1) TW199891B (pt)
WO (1) WO1993002060A1 (pt)
ZA (1) ZA925469B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2111446C (en) * 1991-07-22 1997-12-16 George J. Quallich Chiral intermediates for the preparation of antidiabetics thiazoles
FR2699172B1 (fr) * 1992-12-11 1995-01-20 Adir Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
TW416958B (en) * 1993-05-14 2001-01-01 Pfizer Enantioselective oxazaborolidine catalysts
EA200200311A1 (ru) * 1999-08-31 2002-08-29 Максиа Фармасьютикалз, Инк. Бензилиден-тиазолидиндионы и аналоги и их применение для лечения диабета
AU2002252227A1 (en) 2001-03-07 2002-09-24 Maxia Pharmaceuticals, Inc. Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
JP2004523571A (ja) * 2001-03-08 2004-08-05 マキシア・ファーマシューティカルズ・インコーポレイテッド Rxr活性化分子
CA2340824A1 (en) * 2001-03-14 2002-09-14 Ibm Canada Limited-Ibm Canada Limitee Method and system for application behavior analysis
US20030083357A1 (en) * 2001-08-17 2003-05-01 Magnus Pfahl Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
AU2002352706A1 (en) * 2001-11-15 2003-06-10 Maxia Pharmaceuticals, Inc. N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US7196108B2 (en) * 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US20050014767A1 (en) * 2003-01-29 2005-01-20 Magnus Pfahl Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
JP2006523724A (ja) * 2003-04-18 2006-10-19 インサイト サン ディエゴ インコーポレイテッド 代謝障害、癌および他の疾患の治療のための置換イソクロマン化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
TW222626B (pt) * 1991-07-22 1994-04-21 Pfizer

Also Published As

Publication number Publication date
CA2111445C (en) 1997-02-18
IL102574A0 (en) 1993-01-14
MX9204278A (es) 1994-03-31
FI940306A (fi) 1994-01-21
AU660701B2 (en) 1995-07-06
ES2123562T3 (es) 1999-01-16
NZ243651A (en) 1994-01-26
PT100710B (pt) 1999-07-30
ATE173728T1 (de) 1998-12-15
JPH07502017A (ja) 1995-03-02
IE922359A1 (en) 1993-01-27
DE69227689T2 (de) 1999-04-22
HUT70412A (en) 1995-10-30
PT100710A (pt) 1993-09-30
DK0595868T3 (da) 1999-08-09
MY131277A (en) 2007-07-31
US5512689A (en) 1996-04-30
JP2671962B2 (ja) 1997-11-05
CA2111445A1 (en) 1993-02-04
HU9400188D0 (en) 1994-05-30
EP0595868B1 (en) 1998-11-25
AU2306292A (en) 1993-02-23
WO1993002060A1 (en) 1993-02-04
DE69227689D1 (de) 1999-01-07
ZA925469B (en) 1994-01-21
NO940227D0 (no) 1994-01-21
TW199891B (pt) 1993-02-11
NO940227L (no) 1994-01-21
IL102574A (en) 1996-07-23
EP0595868A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
FI940306A0 (fi) Menetelmä kiraalisten tiatsolidiini-2,4-dionijohdannaisten synteesissä tarvittavien välituotteiden valmistamiseksi
AR038430A2 (es) Derivados de parahercuamida b
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
GR3036305T3 (en) Chiral methyl phenyl oxazolidinones
FI102069B (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmist amiseksi
PT87717A (pt) Process for preparing 2,4-thiazolidinedione derivatives
TW334430B (en) Preparation process for benzoyl derivatives and its intermediates
ES2086065T3 (es) Preparacion de tetrahidropiridinas sustituidas.
AU686955B2 (en) Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives
NO20032401D0 (no) Fremgangsmåte ved fremstilling av taksanderivater
NO885100L (no) Anvendelse av 1,3-butandiolacetoacetat som naeringsmiddel,saerlig for parenteral tilfoersel.
FI906084A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 5-(2-metyyli-4,4,4-trifluoributyylikarbamoyyli)indolijohdannaisten valmistamiseksi
ATE196292T1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
HUT63621A (en) Process for producing new oxazolidine derivatives
ATE259800T1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
ES2033256T3 (es) Procedimiento para preparar derivados fluorados de la vitamina d3.
JPS5620584A (en) Novel oxygenncontaining heterocyclic compound
NO980937L (no) Fremgangsmåte for fremstilling av benzyl-substituerte rhodaninderivater
DE3864286D1 (de) Herstellungsverfahren von trifluormethylverbindungen.
AU652099C (en) Alkene intermediates for the production of certain 1,2-dioxetane compounds
AU4153293A (en) Alkene intermediates for the production of certain 1,2-dioxetane compounds
HU9201664D0 (en) Process for the production of intermedier nizatidine and its derivatives
PH24971A (en) N2-thiocylcarbazate compounds and derivatives thereof
FI883339A0 (fi) Menetelmä -2',3'-dideoksi-inosiinin valmistamiseksi entsymaattisella deaminoinnilla
FI973206A (fi) Menetelmä välituotteina käyttökelpoisten halogeeniasetamidijohdannaisten valmistamiseksi